Encorium Group, Inc. Schedules Fourth Quarter Financial Results and Conference Call

WAYNE, Pa.--(BUSINESS WIRE)--Encorium Group, Inc. (Nasdaq: ENCO), a global clinical research organization in the design, development, and management of complex clinical trials and patient registries for many of the world's leading pharmaceutical and biotechnology companies, announced today that it will issue its financial results for the fourth quarter of 2007 on Tuesday, March 25, 2008 after the close of the stock market, with an accompanying conference call on Wednesday, March 26, 2008 at 11:00 A.M. ET.
MORE ON THIS TOPIC